These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11170105)

  • 1. The drug resistance proteins, multidrug resistance-associated protein and P-glycoprotein, do not confer resistance to Fas-induced cell death.
    Cullen K; Davey R; Davey M
    Cytometry; 2001 Mar; 43(3):189-94. PubMed ID: 11170105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance does not correlate with resistance to Fas-mediated apoptosis.
    Cullen KV; Davey RA; Davey MW
    Leuk Res; 2001 Jan; 25(1):69-75. PubMed ID: 11137563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells.
    Wu QL; Wu XP; Liang YJ; Chen LM; Ding Y; Fu LW
    World J Gastroenterol; 2005 Jun; 11(23):3544-8. PubMed ID: 15962371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death.
    Johnstone RW; Cretney E; Smyth MJ
    Blood; 1999 Feb; 93(3):1075-85. PubMed ID: 9920858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ; Kakehi Y; Yoshida O
    Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.
    Smyth MJ; Krasovskis E; Sutton VR; Johnstone RW
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7024-9. PubMed ID: 9618532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
    Barrand MA; Bagrij T; Neo SY
    Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
    Draper MP; Martell RL; Levy SB
    Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
    Vergote J; Moretti JL; de Vries EG; Garnier-Suillerot A
    Eur J Biochem; 1998 Feb; 252(1):140-6. PubMed ID: 9523723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
    Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
    Stein U; Walther W; Laurencot CM; Scheffer GL; Scheper RJ; Shoemaker RH
    J Natl Cancer Inst; 1997 Jun; 89(11):807-13. PubMed ID: 9182980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases).
    Los M; Herr I; Friesen C; Fulda S; Schulze-Osthoff K; Debatin KM
    Blood; 1997 Oct; 90(8):3118-29. PubMed ID: 9376593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
    Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
    Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug concentration-dependent expression of multidrug resistance-associated protein and P-glycoprotein in the doxorubicin-resistant acute myelogenous leukemia sublines.
    Choi CH; Kim HS; Rha HS; Jeong JH; Park YH; Min YD; Kee KH; Lim DY
    Mol Cells; 1999 Jun; 9(3):314-9. PubMed ID: 10420992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
    Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.